Verificando…
Traduzido automaticamente. Doses e advertências: confira o original em inglês. Ler em inglês

Eltrombopag

Eltrombopag is a thrombopoietin receptor agonist indicated: for the treatment of thrombocytopenia in adult and pediatric patients 1 year and older wit.

Checked against the official label · Updated

MEDICAMENTO SUJEITO A RECEITA MÉDICA Oral Alertas de segurança registados

Eltrombopag: quick answers

Used for
Eltrombopag is a thrombopoietin receptor agonist indicated: for the treatment of thrombocytopenia in.
Usual adult dose
Adult and pediatric patients 6 years and older, and at 25 mg orally once daily for pediatric patients aged 1 to 5 years.
Children
First-line Severe Aplastic Anemia: Initiate eltrombopag tablets orally once daily at 2.5 mg/kg (in pediatric patients aged 2 to 5 years old), 75 mg (pediatric patients aged 6 to 11 years old) or 150 mg for patients aged 12 years and older concurrently with sta…
With food?
Take eltrombopag tablets without a meal or with a meal low in calcium (≤ 50 mg).
Prescription
Prescription medicine in the United States; rules differ by country.

From the official label (Sep 2025). Your prescription and pharmacist come first.

How to use Eltrombopag

O que diz a bula oficial. Se um médico receitou, siga a receita. Se a bula da sua caixa for diferente, vale a da sua caixa.

Advertência grave: RISK FOR HEPATIC DECOMPENSATION IN PATIENTS WITH CHRONIC HEPATITIS C and RISK OF HEPATOTOXICITY In patients with chronic hepatitis C, eltrombopag in combination with interferon and ribavirin may increase the risk of hepatic decompensation [see Warnings and Precautions (5.1) ] . Eltrombopag may increase the risk of severe and potentially life-threatening hepatotoxicity. Monitor hepatic function and discontinue dosing as recommended [see Warnings and Precautions (5.2) ] . …
Para quem é

Eltrombopag is a thrombopoietin receptor agonist indicated: for the treatment of thrombocytopenia in adult and pediatric patients 1 year and older with persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. Eltrombopag tablets should be used only in patients with ITP whose degree of thrombocytopenia and clinical condition increase the risk for bleeding. ( 1.1 ) for the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy. …

Como tomar e com que frequência
  • Take eltrombopag tablets without a meal or with a meal low in calcium (≤ 50 mg)
  • Take eltrombopag tablets at least 2 hours before or 4 hours after any medications or products containing polyvalent cations, such as antacids, calcium-rich foods, and mineral supplements
  • Persistent or Chronic ITP: Initiate eltrombopag tablets at 50 mg orally once daily for most adult and pediatric patients 6 years and older, and at 25 mg orally once daily for pediatric patients aged 1 to 5 years
  • Dose reductions are needed for patients with hepatic impairment and some patients of East-/Southeast-Asian ancestry
  • Adjust to maintain platelet count greater than or equal to 50 x 10 9 /L
  • Do not exceed 75 mg per day
  • Chronic Hepatitis C-associated Thrombocytopenia: Initiate eltrombopag tablets at 25 mg orally once daily for all patients
  • Adjust to achieve target platelet count required to initiate antiviral therapy
  • Do not exceed a daily dose of 100 mg
  • First-line Severe Aplastic Anemia: Initiate eltrombopag tablets orally once daily at 2.5 mg/kg (in pediatric patients aged 2 to 5 years old), 75 mg (pediatric patients aged 6 to 11 years old) or 150 mg for patients aged 12 years and older concurrently with standard immunosuppressive therapy
  • Reduce initial dose in patients of East-/Southeast-Asian ancestry
  • Modify dosage for toxicity or elevated platelet counts
  • Refractory Severe Aplastic Anemia: Initiate eltrombopag tablets orally at 50 mg once daily. …
Strengths it comes in

Eltrombopag Tablets, 12.5 mg are supplied as white to off-white, round, biconvex, film-coated tablets, free from physical defects, debossed with “C9” one side and plain on other. Each tablet, for oral administration, contains eltrombopag olamine, equivalent to 12.5 mg of eltrombopag free acid. …

Children
  • The safety and efficacy of eltrombopag have been established
  • In pediatric patients 1 year and older with persistent or chronic ITP and in pediatric patients 2 years and older with IST-naïve severe aplastic anemia (in combination with h-ATG and cyclosporine)
  • Safety and efficacy
  • In pediatric patients below the age of 1 year with ITP have not been established
  • Safety and efficacy
  • In pediatric patients with thrombocytopenia associated with chronic hepatitis C and refractory severe aplastic anemia have not been established. …
Older adults

Of the 106 patients in two randomized clinical trials of eltrombopag 50 mg in persistent or chronic ITP, 22% were 65 years of age and over, while 9% were 75 years of age and over. Of the 1,439 patients in two randomized clinical trials of eltrombopag in patients with chronic hepatitis C and thrombocytopenia, 7% were 65 years of age and over, while < 1% were 75 years of age and over. …

While you are taking it
  • Advise the patient or caregiver to read the FDA-approved patient labeling (Medication Guide)
  • Prior to treatment, patients should fully understand and be informed of the following risks and considerations for eltrombopag: Risks Hepatotoxicity Therapy with eltrombopag may be associated with hepatobiliary laboratory abnormalities [see Warnings and Precautions ]
  • Advise patients with chronic hepatitis C and cirrhosis that they may be at risk for hepatic decompensation when receiving eltrombopag with alfa interferon therapy [see Warnings and Precautions ]. …
Talk to a doctor first if
  • None
  • None
Medicines it may not mix with

7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids. Take eltrombopag tablets at least 2 hours before or 4 hours after any medications or products containing polyvalent cations, such as antacids, dairy products, and mineral supplements to avoid significant reduction in absorption of eltrombopag due to chelation [see Dosage and Administration (2.4) , Clinical Pharmacology (12.3) ] . …

Warnings

Hepatotoxicity: Monitor liver function before and during therapy. ( 5.2 ) Increased Risk of Death and Progression of Myelodysplastic Syndromes to Acute Myeloid Leukemia. ( 5.3 ) Thrombotic/Thromboembolic Complications: Portal vein thrombosis has been reported in patients with chronic liver disease receiving eltrombopag. Monitor platelet counts regularly. ( 5.4 ) 5.1 Hepatic Decompensation in Patients With Chronic Hepatitis C In patients with chronic hepatitis C, eltrombopag in combination with interferon and ribavirin may increase the risk of hepatic decompensation. …

Possíveis efeitos colaterais

The following clinically significant adverse reactions associated with eltrombopag are described in other sections. Hepatic Decompensation in Patients with Chronic Hepatitis C [see Warnings and Precautions (5.1) ] Hepatotoxicity [see Warnings and Precautions (5.2) ] Increased Risk of Death and Progression of Myelodysplastic Syndromes to Acute Myeloid Leukemia [see Warnings and Precautions (5.3) ] Thrombotic/Thromboembolic Complications [see Warnings and Precautions (5.4) ] Cataracts [see Warnings and Precautions (5.5) ] Across all indications, the most common adverse reactions (≥ 20% in any indication) were: anemia, nausea, pyrexia, alanine aminotransferase increased, cough, fatigue, headach …

Pregnancy and breastfeeding

8.1 Pregnancy Risk Summary Available data from a small number of published case reports and post-marketing experience with eltrombopag use in pregnant women are insufficient to assess any drug-associated risks for major birth defects, miscarriage, or adverse maternal or fetal outcomes. …

If you take too much

In the event of overdose, platelet counts may increase excessively and result in thrombotic/thromboembolic complications. In one report, a subject who ingested 5,000 mg of eltrombopag had a platelet count increase to a maximum of 929 x 10 9 /L at 13 days following the ingestion. The patient also experienced rash, bradycardia, ALT/AST elevations, and fatigue. …

Se esquecer uma dose

Tome assim que lembrar, a menos que esteja quase na hora da próxima dose. Nesse caso, pule a dose esquecida. Nunca tome duas doses de uma vez para compensar. Confira a bula, pois alguns medicamentos são diferentes.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2025-09-12.

How much Eltrombopag costs

In other countries

Prices in other countries are not what you will pay where you live; they show how prices compare.

Marcas pelo mundo

Products with Eltrombopag as the active ingredient. Names differ between countries.

Registered products

United States (FDA)

PromactaELTROMBOPAG OLAMINE 25 mg/1 · Tablet, Film Coated · Novartis Pharmaceuticals Corporation
NDC 0078-0685Label
EltrombopagELTROMBOPAG OLAMINE 12.5 mg/1 · Tablet, Film Coated · Teva Pharmaceuticals, Inc.
NDC 0480-4015Label
PromactaELTROMBOPAG OLAMINE 50 mg/1 · Tablet, Film Coated · Novartis Pharmaceuticals Corporation
NDC 0078-0686Label
EltrombopagELTROMBOPAG OLAMINE 12.5 mg/1 · Tablet, Film Coated · Quallent Pharmaceuticals Health LLC
NDC 82009-198Label
EltrombopagELTROMBOPAG OLAMINE 25 mg/1 · Tablet, Film Coated · Quallent Pharmaceuticals Health LLC
NDC 82009-199Label

Other countries: check your pack's registration number and we point you to your regulator.

Safety alerts and recalls

Promacta (eltrombopag) 12.5 mg for Oral Suspension, Rx Only Manufactured by: Halo Pharmaceuticals, Inc. Whippany, New Jersey 07981 Distributed by: Novartis Pharmaceuticals CorpoU.S. FDA Class I
11 May 2019 · Novartis Pharmaceuticals Corp. · TerminatedCross Contamination with Other Products: product is being recalled due to possible cross-contamination with peanut flour.

A recall usually affects certain batches only. Compare the lot number on your pack.

Check your pack of Eltrombopag

Type the registration number on the pack, or scan it with your camera.

Ou tire fotos da caixa
Restam 3 verificações grátis hoje Official sources: U.S. FDA · EMA (EU) · Health Canada · WHO alerts

Questions about Eltrombopag

What is Eltrombopag used for?

Eltrombopag is a thrombopoietin receptor agonist indicated: for the treatment of thrombocytopenia in adult and pediatric patients 1 year and older with persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. Eltrombopag tablets should be used only in patients with ITP whose degree of thrombocytopenia and clinical condition increase (From the official U.S. FDA label.)

How do I take Eltrombopag?

Follow your prescription or the leaflet in your pack. The official label says: Take eltrombopag tablets without a meal or with a meal low in calcium (≤ 50 mg). Take eltrombopag tablets at least 2 hours before or 4 hours after any medications or products containing polyvalent cations, such as antacids, calcium-rich foods, and mineral supplements. ( 2.4 , 7.1 , 12.3 ) Persistent or Chronic ITP: Initiate eltrombopag tablets at 50 mg orally once daily for mos…

Should I take Eltrombopag with food?

Take eltrombopag tablets without a meal or with a meal low in calcium (≤ 50 mg).

Do I need a prescription for Eltrombopag?

Usually yes. Eltrombopag is a prescription medicine in most countries. Rules differ by country.

What brands contain Eltrombopag?

Eltrombopag is sold under names such as Alvaiz, Promacta, Eltrombopag Olamine. Brand names differ between countries.

What are the side effects of Eltrombopag?

The official label lists: The following clinically significant adverse reactions associated with eltrombopag are described in other sections. Hepatic Decompensation in Patients with Chronic Hepatitis C [see Warnings and Precautions (5.1) ] Hepatotoxicity [see Warnings and Precautions (5.2) ] Increased Risk of Death and Progression of Myelodysplastic Syndromes to Acute Myeloid Leukemia [see Warnings and… Tell your doctor about any side effect that bothers you or does not go away.

Can children take Eltrombopag?

The safety and efficacy of eltrombopag have been established in pediatric patients 1 year and older with persistent or chronic ITP and in pediatric patients 2 years and older with IST-naïve severe aplastic anemia (in combination with h-ATG and cyclosporine). Safety and efficacy in pediatric patients below the age of 1 year with ITP have not been established. Safety and efficacy… Always use the dose for the child's age or weight on the pack or prescription.

Can I take Eltrombopag when pregnant or breastfeeding?

8.1 Pregnancy Risk Summary Available data from a small number of published case reports and post-marketing experience with eltrombopag use in pregnant women are insufficient to assess any drug-associated risks for major birth defects, miscarriage, or adverse maternal or fetal outcomes. … Ask your doctor or midwife first.

What medicines interact with Eltrombopag?

7.1 Polyvalent Cations (Chelation) Eltrombopag chelates polyvalent cations (such as iron, calcium, aluminum, magnesium, selenium, and zinc) in foods, mineral supplements, and antacids. Take eltrombopag tablets at least 2 hours before or 4 hours after any medications or products containing polyvalent cations, such as antacids, dairy products, and mineral supplements to avoid sig… Use the free interaction checker before combining medicines.

What happens if I take too much Eltrombopag?

In the event of overdose, platelet counts may increase excessively and result in thrombotic/thromboembolic complications. In one report, a subject who ingested 5,000 mg of eltrombopag had a platelet count increase to a maximum of 929 x 10 9 /L at 13 days following the ingestion. The patient also exp… Get medical help right away.

How can I check that my Eltrombopag is genuine?

Scan the registration number on your pack with PillVera (NAFDAC number in Nigeria, NDC in the United States, DIN in Canada), check the expiry date and buy only from licensed pharmacies.

Sources

This page shows what official sources say, in plain words. It is not medical advice: your prescription and your doctor or pharmacist come first. Brand names, strengths and rules differ between countries.